Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Zoetis Inc. (NYSE:ZTS) Shares Sold by Neville Rodie & Shaw Inc.
08:26pm, Monday, 15'th Nov 2021 Transcript Daily
Neville Rodie & Shaw Inc. cut its position in shares of Zoetis Inc. (NYSE:ZTS) by 1.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 141,726 shares of the company’s stock after selling 2,233 shares during the period. Zoetis accounts for about […]
The research authors at Transparency Market Research have placed the evaluation of the global veterinary vaccines market at US$ 6,100 million in the year of 2017. They predict that the global veterinary vaccines market will grow at an exemplary CAGR
Veterinary Pain Management market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 13.55% in the above-mentioned forecast period. Rise in the
Animal Parasiticides Market Expected to Record the Massive Growth and Prominent Key Players Zoetis, Merck, Elanco, Bayer, Virbac, Vetoquinol, Chanelle
06:21am, Monday, 15'th Nov 2021 OpenPR
Animal Parasiticides Market research report is a complete overview of the market, covering various aspects like the product definition, segmentation based on various parameters, and the prevailing vendor landscape. the industry is anticipated to witness higher growth during the forecast
Animal care: People are ‘investing more in their pets' wellness,' Zoetis CFO says
12:34pm, Monday, 08'th Nov 2021
Zoetis CFO Wetteny Joseph joins Yahoo Finance's Emily McCormick to discuss Q3 earnings, global trends for pet health care, and COVID vaccines for animals. Don't Miss: Valley of Hype: The Culture That
There's a 'long tail' to Zoetis' growth, CEO believes
04:40pm, Thursday, 04'th Nov 2021
Kristin Peck, Zoetis CEO, joins 'Closing Bell' to give a candid look at the company's Q3 earnings results and where Zoetis has seen steady, durable growth. Peck says they're on track for the company's
Zoetis Inc. (ZTS) CEO Kristin Peck on Q3 2021 Results - Earnings Call Transcript
02:01pm, Thursday, 04'th Nov 2021
Zoetis Inc. (ZTS) CEO Kristin Peck on Q3 2021 Results - Earnings Call Transcript
Zoetis' (ZTS) Earnings and Revenues Surpass Estimates in Q3
11:28am, Thursday, 04'th Nov 2021
Zoetis' (ZTS) earnings and revenues beat estimates in the third quarter of 2021. The company raised its financial guidance for 2021.
Zoetis (ZTS) Beats Q3 Earnings and Revenue Estimates
09:57am, Thursday, 04'th Nov 2021
Zoetis (ZTS) delivered earnings and revenue surprises of 13.64% and 2.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Zoetis (ZTS) This Earnings Season?
11:29am, Wednesday, 03'rd Nov 2021
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
01:49pm, Monday, 01'st Nov 2021
Zoetis (ZTS) is set to report earnings and revenues, and provide updates on its diversified product portfolio when it releases third-quarter 2021 results.
4 Big Drug, Biotech Stocks Set to Beat Q3 Earnings Estimates
12:59pm, Friday, 29'th Oct 2021
Let us take a look at some drug/biotech stocks that are poised to beat on third-quarter earnings.
ETO: A Solid Dividend Fund But Expensive
12:41pm, Wednesday, 27'th Oct 2021
ETO: A Solid Dividend Fund But Expensive
Zoetis: Expensive But Precision Livestock Farming Division Could Be Game Changer
01:11pm, Tuesday, 26'th Oct 2021
Zoetis is the leader in pharmaceutical drugs, nutrition, and diagnostics for companion animals and livestock.
Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
05:06pm, Monday, 18'th Oct 2021
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #ResearchandDevelopment--Robert J. Polzer, PhD, will succeed current EVP and President of R&D at Zoetis, Dr. Catherine Knupp, DVM, MS.
